A 50 % Indian tariff could upend cost structures across cannabis pre-rolls

Study across 20 countries finds medical cannabis linked to reduced tobacco and amphetamine use, suggesting public health benefits.

Congress will probe alleged Chinese ties to illegal marijuana grows. Here’s what’s at stake for cannabis policy and national security.

Delta-8 THC Ruled Illegal in Maryland—Why Arizona Businesses Should Watch Closely

Congress cuts cannabis banking protections from 2025 bill, leaving legal operators at risk

Critics of federal cannabis reform claim it benefits criminals, but experts say rescheduling is key to regulation, research, and tax fairness.

Ohio now allows cannabis pre-rolls, aligning with national trends and boosting adult-use sales. Convenience and demand drive the change.

Nano-emulsions are redefining cannabis absorption and onset speed, offering users faster effects, greater potency, and more reliable dosing.

President Trump confirmed Aug 11, 2025, that his administration is reviewing cannabis reclassification to Schedule III, with a decision expected soon.

The cannabis preroll market is booming, with $3.1B in sales, new product tech, and Arizona brands shaping national trends.

Mini joints are redefining cannabis consumption with precise dosing, portability, and personalized experiences tailored to modern lifestyles.

Colorado’s SB25-297 strengthens psychedelic reform by combining clemency powers, data-driven oversight, and regulatory updates to guide safe, equitable implementation.